Skip to main content
. 2021 Dec 21;7(3):638–641. doi: 10.1016/j.ekir.2021.12.019

Figure 1.

Figure 1

Changes in (a) 24-hour urine protein, (b) plasma albumin, (c) eGFR, and (d) BMI during dapagliflozin treatment. Absolute values were shown as mean, error bars were shown as SD. Data were from 8 patient who completed the treatment period. The baseline and posttreatment parameters were compared using paired t test; ∗P < 0.05. BMI, body mass index; eGFR, estimated glomerular filtration rate; ns, no significant difference.